Abstract
Introduction: Ursodeoxycholic acid (UDCA) treatment of patients with primary sclerosing cholangitis appears to reduce the risk of colon cancer. UDCA prevents colon cancer in animal models; the mechanism of the chemopreventive action is still unknown. We investigated the effects of UDCA on proliferation of colon cancer cells in vitro.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
